Mark A. Goldsmith
CIK: 0001246842
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Revolution Medicines, Inc.
Discretionary Trading P&L
Holdings
Transaction History (82 total)
- Sep 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct13.8K shares at avg. $199.30$2.7M - Sep 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct213 shares at avg. $195.01$42K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect126 shares at avg. $212.06$27K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct5.1K shares at avg. $207.23$1.1M - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect1.4K shares at avg. $209.27$294K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect229 shares at avg. $211.46$48K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect190 shares at avg. $207.25$39K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect951 shares at avg. $208.36$198K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect1.4K shares at avg. $209.28$283K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect127 shares at avg. $212.06$27K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct35.9K shares at avg. $209.26$7.5M - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct3.8K shares at avg. $210.25$802K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct80K shares at avg. $4.73$378K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect126 shares at avg. $210.40$27K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct24.9K shares at avg. $208.37$5.2M - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect937 shares at avg. $208.36$195K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct6.6K shares at avg. $211.33$1.4M - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct3.6K shares at avg. $212.08$768K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect245 shares at avg. $211.47$52K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect177 shares at avg. $207.25$37K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Indirect136 shares at avg. $210.40$29K - Jun 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct10K shares at avg. $156.12$1.6M - Apr 15, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct120K shares at avg. $150.09$18.0M - Apr 15, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct23.2K shares at avg. $4.09$95K - Apr 15, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct96.8K shares at avg. $4.73$458K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 13,775 | $199.30 | $2,745,402 | Direct |
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 213 | $195.01 | $41,537 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 126 | $212.06 | $26,720 | Indirect |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 5,128 | $207.23 | $1,062,691 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,405 | $209.27 | $294,019 | Indirect |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 229 | $211.46 | $48,425 | Indirect |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 190 | $207.25 | $39,377 | Indirect |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 951 | $208.36 | $198,155 | Indirect |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,351 | $209.28 | $282,739 | Indirect |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 127 | $212.06 | $26,932 | Indirect |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 35,938 | $209.26 | $7,520,440 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 3,813 | $210.25 | $801,670 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 80,000 | $4.73 | $378,400 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 126 | $210.40 | $26,511 | Indirect |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 24,917 | $208.37 | $5,191,948 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 937 | $208.36 | $195,234 | Indirect |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 6,583 | $211.33 | $1,391,206 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 3,621 | $212.08 | $767,933 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 245 | $211.47 | $51,809 | Indirect |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 177 | $207.25 | $36,684 | Indirect |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 136 | $210.40 | $28,615 | Indirect |
| Jun 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 10,020 | $156.12 | $1,564,310 | Direct |
| Apr 15, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 120,000 | $150.09 | $18,010,488 | Direct |
| Apr 15, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 23,244 | $4.09 | $95,068 | Direct |
| Apr 15, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 96,756 | $4.73 | $457,656 | Direct |
1-25 of 82 transactions
About GOLDSMITH MARK A
GOLDSMITH MARK A (SEC CIK 0001246842) files insider reports with the SEC as Director of Revolution Medicines, Inc. (RVMD).
Signal8 holds 24 ownership filings by GOLDSMITH MARK A, all Form 4s, filed between Sep 18, 2024 and Sep 18, 2026. Those filings report 82 transactions, from Sep 16, 2024 to Sep 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on GOLDSMITH MARK A's filings is in REDWOOD CITY, CA.
Recent filings by GOLDSMITH MARK A
- Sep 16, 2026: Open-market sales of RVMD shares (2 lines, Form 4, code S).
- Aug 21, 2026: Open-market sales of RVMD shares (10 lines, Form 4, code S).
- Aug 21, 2026: Option exercise of RVMD shares (Form 4, code M).
- Aug 21, 2026: Open-market sales of RVMD shares (8 lines, Form 4, code S).
- Jun 16, 2026: Open-market sale of RVMD shares (Form 4, code S).
Other insiders filing for Revolution Medicines, Inc. (RVMD)
- Mancini Anthony
- Sandler Alan B., Chief Development Officer
- Cislini Jeff, SVP & General Counsel
- ANDERSON ELIZABETH M, Director
- Kelsey Stephen Michael
- Horn Margaret A, Chief Operating Officer